Iksuda Therapeutics are featured in this month’s Nature magazine, a Q&A with their Chief Science Officer, Bob Lutz – Forging stable relationships for antibody-drug conjugates. Click on the link for the full article https://www.nature.com/articles/d42473-019-00358-3
